<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>LSE:AZN on 无关紧要的宇宙</title><link>https://316140221.github.io/Hugo/zh/tags/lseazn/</link><description>Recent content in LSE:AZN on 无关紧要的宇宙</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Tue, 29 Jul 2025 20:00:14 +0800</lastBuildDate><atom:link href="https://316140221.github.io/Hugo/zh/tags/lseazn/index.xml" rel="self" type="application/rss+xml"/><item><title>AstraZeneca Profit, Revenue Lifted by Cancer Drugs</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-astrazeneca-profit-revenue-lifted-by-cancer-drugs/</link><pubDate>Tue, 29 Jul 2025 20:00:14 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-astrazeneca-profit-revenue-lifted-by-cancer-drugs/</guid><description>AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US. Chief Executive Officer Pascal Soriot has</description></item><item><title>AstraZeneca Profit, Revenue Lifted by Cancer Drugs</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-astrazeneca-profit-revenue-lifted-by-cancer-drugs/</link><pubDate>Tue, 29 Jul 2025 20:00:14 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-astrazeneca-profit-revenue-lifted-by-cancer-drugs/</guid><description>AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US. Chief Executive Officer Pascal Soriot has</description></item></channel></rss>